Literature DB >> 27293390

Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor.

Kosuke Shido1, Taku Fujimura1, Aya Kakizaki1, Sadanori Furudate1, Masayuki Asano1, Setsuya Aiba1.   

Abstract

Plexiform fibrohistiocytic tumor (PFT) is a rare mesenchymal neoplasm of intermediate malignant potential with a high local recurrence rate. In this report, we describe a case of PFT on the ear, which showed a dense deposition of periostin (POSTN) in the stromal areas of the tumor. In addition, dense infiltration of CD163+CD206- tumor-associated macrophages (TAMs) was detected in the same areas as POSTN. Since POSTN was previously reported to possess immunomodulatory effects on TAMs, our present report suggested the significance of the POSTN/TAMs axis in the progression of PFT.

Entities:  

Keywords:  Immunomodulation; Periostin; Plexiform fibrohistiocytic tumor; Tumor-associated macrophages

Year:  2016        PMID: 27293390      PMCID: PMC4899637          DOI: 10.1159/000444045

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Plexiform fibrohistiocytic tumor (PFT) presents as a slowly developing nodule on the extremities and trunk [1, 2], and generally occurs in children and young adults [1, 2]. Although approximately 150 cases have been presented in English language papers about PFT [1, 2, 3, 4], little is known about its pathogenesis.

Case Report

A 28-year-old Japanese woman visited our outpatient clinic with a 1.5-year history of an asymptomatic nodule developing on her left retroauricular skin. Her tumor had been resected by a general surgeon as a benign spindle cell tumor without further histological diagnosis 1 year before. On her initial visit, physical examination revealed a well-demarcated nodule on her retroauricular skin, 20 × 20 mm in size (fig. 1a). Magnetic resonance imaging revealed a subcutaneous nodule located adjacent to the periosteum (fig. 1b). We excised the nodule together with the adjacent periosteum with a 5-mm surgical margin. The histopathological findings revealed proliferation of fibroblastic and histiocytic cells showing storiform-type whorling and a plexiform pattern (fig. 1c, d). These tumor-composing spindle cells were positive for CD68 and SMA, and negative for S100 and factor XIIIa. The Ki67 score was approximately 10%. Based on the above finding, we diagnosed this tumor as a PFT. The differential diagnoses of PFT are listed in table 1 [2].
Fig. 1

a A well-demarcated nodule on the retroauricular skin, 20 × 20 mm in size. b Magnetic resonance imaging revealed a subcutaneous nodule located adjacent to the periosteum. c, d Proliferation of fibroblastic and histiocytic cells showing storiform-type whorling and a plexiform pattern. Original magnification: ×100 (c), ×400 (d).

Table 1

Differential diagnoses of PFT

How to differentiate from PFT
Plexiform neurofibromaS100+
Plexiform schwannomaS100+
Cellular neurothekeomaS100+
Fibrous hamartoma of infancypossesses the primitive cellular myxoid component
Benign fibrous histiocytomasolid-pattern tumor
Dermatofibromastoriform-pattern tumor
Myofibromatosiswell-demarcated with a zoned appearance
Since the pathogenesis and biological behavior of PFT are still incompletely understood, we employed immunohistochemical staining for periostin (POSTN), CD163 and CD206 to further investigate the possible immunological background of the PFT. A dense deposition of POSTN was detected throughout the stromal areas of the tumor (fig. 2a). In addition, CD163+CD206tumor-associated macrophages (TAMs) were densely infiltrated in the same areas of POSTN (fig. 2b, c).
Fig. 2

Paraffin-embedded tissue samples were deparaffinized and stained with anti-POSTN antibody (a), anti-CD163 antibody (b) and anti-CD206 antibody (c). The sections were developed with liquid permanent red. Original magnification: ×200.

Discussion

In this report, we describe a case of PFT on the ear which showed a dense deposition of POSTN in the stromal areas of the tumor. PFT is a rare mesenchymal neoplasm of intermediate malignant potential with a high local recurrence rate, like dermatofibrosarcoma protuberans [1, 2, 3, 4]. Immunohistochemical staining is helpful for the differential diagnosis of PFT [1, 2]: e.g. it is positive for CD68, vimentin and NSE, and negative for S100, CD34, factor XIIIa and calponin [2, 3]. Since these diagnostic markers for PFT do not reflect the biological behavior of this type of malignant tumor, in this report we employed immunohistochemical staining for POSTN as well as CD163 and CD206, focusing on the cancer stroma of PFT to investigate the possible mechanisms of local invasion and recurrence of PFT. POSTN is an extracellular matrix protein that is involved in modulating cell functions through various pathways [5, 6, 7]. In the dermatological field, the deposition of POSTN is reported in various skin diseases, including fibrosing diseases such as keloid, hypertrophic scar [8], morphea and lichen sclerosis et atrophicus [9]. Zhou et al. [6] reported the importance of POSTN in developing glioblastoma multiforme by the induction of M2-like TAMs in the tumor microenvironment. In addition, as we previously reported, POSTN stimulates CD163+CD206– monocyte-derived macrophages to produce a series of chemokines that might be connected with the cancer formation of mycosis fungoides [7]. Notably, this study also suggests that CD163+CD206– monocyte-derived macrophages augment the mRNA expression of MMP12 by POSTN stimulation. Interestingly, MMP12 is reported to be increased in the serum and skin lesions of systemic sclerosis, and is associated with the severity of skin and pulmonary fibrosis [10]. These reports suggested the significance of the POSTN/TAMs axis in the progression of various types of tumors, and suggested that POSTN stimulation might modulate the function of CD163+CD206– TAMs to develop the fibrosis in PFT. To confirm this hypothesis, further cases and studies will be necessary.

Statement of Ethics

The patient gave written informed consent.

Disclosure Statement

The authors have no conflicting interests to declare.
  10 in total

1.  Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions.

Authors:  Kyaw Lynnhtun; Anita Achan; Meena Shingde; Shaun Chou; Julie Riina Howle; Raghwa Sharma
Journal:  Histopathology       Date:  2012-03-21       Impact factor: 5.087

2.  Extracellular matrix molecules implicated in hypertrophic and keloid scarring.

Authors:  G P Sidgwick; A Bayat
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-08-12       Impact factor: 6.166

3.  An unusual occurence of plexiform fibrohistiocytic tumour: congenital tumour diagnosed at 7 years of age.

Authors:  Bahar Muezzinoglu; Aysegul Tohumcu; Gulsen Ekingen
Journal:  Pathology       Date:  2011-06       Impact factor: 5.306

4.  Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.

Authors:  Mirko Manetti; Serena Guiducci; Eloisa Romano; Silvia Bellando-Randone; Maria Letizia Conforti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2012-01-17       Impact factor: 19.103

5.  Neurothekeoma and plexiform fibrohistiocytic tumor: mere histologic resemblance or histogenetic relationship?

Authors:  Shabnam Jaffer; Andrea Ambrosini-Spaltro; Antonio M Mancini; Vincenzo Eusebi; Juan Rosai
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

Review 6.  Plexiform fibrohistiocytic tumor: a brief review.

Authors:  Altaf Taher; Chitra Pushpanathan
Journal:  Arch Pathol Lab Med       Date:  2007-07       Impact factor: 5.534

7.  The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.

Authors:  Sadanori Furudate; Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Masayuki Asano; Akiko Watabe; Setsuya Aiba
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960

8.  Critical role for mast cell Stat5 activity in skin inflammation.

Authors:  Tomoaki Ando; Wenbin Xiao; Peisong Gao; Siavash Namiranian; Kenji Matsumoto; Yoshiaki Tomimori; Hong Hong; Hirotaka Yamashita; Miho Kimura; Jun-Ichi Kashiwakura; Tissa R Hata; Kenji Izuhara; Michael F Gurish; Axel Roers; Nicholas M Rafaels; Kathleen C Barnes; Colin Jamora; Yuko Kawakami; Toshiaki Kawakami
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

9.  Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.

Authors:  Wenchao Zhou; Susan Q Ke; Zhi Huang; William Flavahan; Xiaoguang Fang; Jeremy Paul; Ling Wu; Andrew E Sloan; Roger E McLendon; Xiaoxia Li; Jeremy N Rich; Shideng Bao
Journal:  Nat Cell Biol       Date:  2015-01-12       Impact factor: 28.824

10.  Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study.

Authors:  Aya Kakizaki; Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2015-03-10
  10 in total
  1 in total

1.  A Case of Plexiform Fibrohistiocytic Tumor on Finger.

Authors:  Young Jae Kim; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Woo Jin Lee
Journal:  Ann Dermatol       Date:  2018-04-23       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.